Mizuho on Boston Scientific (BSX): 'we do not foresee any FTC risk concerns'
Tweet Send to a Friend
Mizuho analyst Anthony Petrone reiterated an Outperform rating and $140.00 price target on Boston Scientific (NYSE: BSX).The analyst comments "Last ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
